91
Views
3
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis

Plasma acrolein level in rheumatoid arthritis increases independently of the disease characteristics

, , , , , , , , & show all
Pages 357-364 | Received 28 Feb 2020, Accepted 18 May 2020, Published online: 16 Jun 2020

References

  • Sharmin S, Sakata K, Kashiwagi K, Ueda S, Iwasaki S, Shirahata A, et al. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun. 2001;282(1):228–35.
  • Igarashi K, Kashiwagi K. Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol Nutr Food Res. 2011;55(9):1332–41.
  • Moghe A, Ghare S, Lamoreau B, Mohammad M, Barve S, McClain C, et al. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol Sci. 2015;143(2):242–55.
  • Tomitori H, Usui T, Saeki N, Ueda S, Kase H, Nishimura K, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke. 2005;36(12):2609–13.
  • Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol. 2010;42(1):39–51.
  • Brooks WH. Autoimmune diseases and polyamines. Clin Rev Allergy Immunol. 2012;42(1):58–70.
  • Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, et al. Increase in putrescine, amino oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun. 2003;305(1):143–9.
  • Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, et al. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA. 1998;95(9):4882–7.
  • Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, et al. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis. 2010;211(2):475–9.
  • Saiki R, Nishimura K, Ishii I, Omura T, Okuyama S, Kashiwagi K, et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke. 2009;40(10):3356–61.
  • Hirose T, Saiki R, Uemura T, Suzuki T, Dohmae N, Ito S, et al. Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome. Clin Chim Acta. 2015;450(23):184–9.
  • Tsou HH, Hsu WC, Fuh JL, Chen SP, Liu TY, Wang HT. Alterations in acrolein metabolism contribute to Alzheimer's Disease. J Alzheimers Dis. 2018;61(2):571–80.
  • Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol. 2007;26(1):64–8.
  • EL-Maghrabey MH, Kishikawa N, Ohyama K, Kuroda N. Analytical method for lipoperoxidation relevant reactive aldehydes in human sera by high-performance liquid chromatography-fluorescence detection. Anal Biochem. 2014;464:36–42.
  • Łuczaj W, Gindzienska-Sieskiewicz E, Jarocka-Karpowicz I, Andrisic L, Sierakowski S, Zarkovic N, et al. The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radic Res. 2016;50(3):304–13.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
  • Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem. 1998;273(26):16058–66.
  • Yoshida M, Tomitori H, Machi Y, Katagiri D, Ueda S, Horiguchi K, et al. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis. 2009;203(2):557–62.
  • Uemura T, Watanabe K, Ishibashi M, Saiki R, Kuni K, Nishimura K, et al. Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging. Biochem Biophys Res Commun. 2016;473(2):630–5.
  • Igarashi K, Uemura T, Kashiwagi K. Acrolein toxicity at advanced age: present and future. Amino Acids. 2018;50(2):217–28.
  • Pratt AG, Isaacs JD. Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects. Best Pract Res Clin Rheumatol. 2014;28(4):651–9.
  • Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis. 2004;63(9):1079–84.
  • Mun S, Lee J, Lim M-K, Lee Y-R, Ihm C, Lee SH, et al. Development of a novel diagnostic biomarker set for rheumatoid arthritis using a proteomics approach. Biomed Res Int. 2018;2018:7490723
  • Ferrante A, Storer RJ, Cleland LJ. Polyamine oxidase activity in rheumatoid arthritis synovial fluid. Clin Exp Immunol. 1990;80(3):373–5.
  • Yukioka K, Wakitani S, Yukioka M, Furumitsu Y, Shichikawa K, Ochi T, et al. Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis. J. Rheumatol 1992;19(5):689–92.
  • Furumitsu Y, Yukioka K, Yukioka M, Ochi T, Morishima Y, Matsui-Yuasa I, et al. Interleukin-1β induces elevation of spermidine/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis. J Rheumatol. 2000;27(6):1352–7.
  • Karouzakis E, Gay RE, Gay S, Neidhart M. Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2012;64(6):1809–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.